The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1575
ISSUE1575
July 1, 2019
Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms
July 1, 2019 (Issue: 1575)
The FDA has approved Bijuva (TherapeuticsMD), a
fixed-dose combination of estradiol and progesterone,
for oral treatment of moderate to severe vasomotor
symptoms (hot flashes) due to menopause in women
with an intact uterus. The manufacturer is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.